Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 4/20 | 0.36 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.35 |
| ▸ | TPH1 | P17752 | 1/20 | 0.34 |
| ▸ | DRD1 | P21728 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2839430 | 0.86 | UTS2R (0.37) | OPRD1UTS2RTPH1DRD1OPRK1 | |
| SCHEMBL2844559 | 0.86 | OPRD1 (0.37) | OPRD1UTS2RTPH1 | |
| Hydrochloric Acid SCHEMBL2837086 | 0.78 | OPRK1 (0.38) | OPRD1UTS2RTPH1OPRK1OPRM1 | |
| SCHEMBL2843896 | 0.77 | TOP2A (0.38) | — | |
| SCHEMBL2840801 | 0.75 | OPRD1 (0.39) | OPRD1KCNH2 | |
| SCHEMBL2842973 | 0.73 | TPH1 (0.34) | OPRD1UTS2RTPH1OPRK1OPRM1 | |
| SCHEMBL2840576 | 0.73 | DRD3 (0.36) | DRD1OPRK1OPRM1KCNH2 | |
| SCHEMBL2873210 | 0.73 | UTS2R (0.37) | OPRD1UTS2RDRD1 | |
| SCHEMBL2834956 | 0.72 | HHAT (0.38) | DRD1 | |
| SCHEMBL2836972 | 0.72 | SLC6A4 (0.34) | OPRD1UTS2ROPRK1OPRM1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8217031-B2 | Heteroaryl derivatives | NIPPON SHINYAKU CO., LTD. (JP) | 2012-07-10 | — | — | US | disclosed |
| US-20100048537-A1 | HETEROARYL DERIVATIVES | NIPPON SHINYAKU CO., LTD. (JP) | 2010-02-25 | — | — | US | disclosed |
| EP-2141168-A1 | HETEROARYL DERIVATIVES | Nippon Shinyaku Co., Ltd. (JP) | 2010-01-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048537-A1 | HETEROARYL DERIVATIVES | OPRD1, OPRM1, OPRK1 | OPRD1 1/4885UTS2R 702/4885TPH1 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.